New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 10, 2024 - Accord announced the FDA approval of Imuldosa (ustekinumab-srlf), biosimilar to Janssen’s Stelara® (ustekinumab).
Download PDF
Return to publications
